Order Article Reprints

Li X, Zhang B, Cheng Y, Chen M, Lin H, Huang B, Que W, Liu M, Zhou L, Weng Q, et al. Evaluation and Validation of the Limited Sampling Strategy of Polymyxin B in Patients with Multidrug-Resistant Gram-Negative Infection. Pharmaceutics. 2022; 14(11):2323. https://doi.org/10.3390/pharmaceutics14112323

Li, Xueyong, Bingqing Zhang, Yu Cheng, Maohua Chen, Hailing Lin, Binglin Huang, Wancai Que, Maobai Liu, Lili Zhou, Qinyong Weng, and et al. 2022. "Evaluation and Validation of the Limited Sampling Strategy of Polymyxin B in Patients with Multidrug-Resistant Gram-Negative Infection" Pharmaceutics 14, no. 11: 2323. https://doi.org/10.3390/pharmaceutics14112323

Li, X., Zhang, B., Cheng, Y., Chen, M., Lin, H., Huang, B., Que, W., Liu, M., Zhou, L., Weng, Q., Zhang, H., & Qiu, H. (2022). Evaluation and Validation of the Limited Sampling Strategy of Polymyxin B in Patients with Multidrug-Resistant Gram-Negative Infection. Pharmaceutics, 14(11), 2323. https://doi.org/10.3390/pharmaceutics14112323